Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations

Infection and Immunity

Volumn 76, Issue 12, 2008, Pages 5438-5446

  Suchland, Robert J ^a   Jeffrey, Brendan M ^b   Xia, Minsheng ^a   Bhatia, Ajay ^c,d   Chu, Hencelyn G ^b,e   Rockey, Daniel D ^b   Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN INCA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE;

ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; BLOTTING, NORTHERN; CHLAMYDIA TRACHOMATIS; CHLAMYDIACEAE INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MEMBRANE PROTEINS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 57349113738     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00984-08     Document Type: Article

References (21)

1. Bannantine, J. P., R. S. Griffiths, W. Viratyosin, W. J. Brown, and D. D. Rockey. 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell. Microbiol. 2:35-47.
2. Bannantine, J. P., W. E. Stamm, R. J. Suchland, and D. D. Rockey. 1998. Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect. Immun. 66:6017-6021.
3. Belland, R. J., M. A. Scidmore, D. D. Crane, D. M. Hogan, W. Whitmire, G. McClarty, and H. D. Caldwell. 2001. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. USA 98:13984-13989.
4. Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31:1161-1176.
5. Clifton, D. R., K. A. Fields, S. S. Grieshaber, C. A. Dooley, E. R. Fischer, D. J. Mead, R. A. Carabeo, and T. Hackstadt. 2004. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 101:10166-10171.
6. Dean, D., R. J. Suchland, and W. E. Stamm. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916.
7. Delevoye, C., M. Nilges, A. Dautry-Varsat, and A. Subtil. 2004. Conservation of the biochemical properties of IncA from Chlamydia trachomatis and Chlamydia caviae: oligomerization of IncA mediates interaction between facing membranes. J. Biol. Chem. 279:46896-46906.
8. Geisler, W. M., R. J. Suchland, D. D. Rockey, and W. E. Stamm. 2001. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J. Infect. Dis. 184:879-884.
9. Hackstadt, T., M. A. Scidmore-Carlson, E. I. Shaw, and E. R. Fischer. 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell. Microbiol. 1:119-130.
10. Jeck, W. R., J. A. Reinhardt, D. A. Baltrus, M. T. Hickenbotham, V. Magrini, E. R. Mardis, J. L. Dangl, and C. D. Jones. 2007. Extending assembly of short DNA sequences to handle error. Bioinformatics 23:2942-2944.
11. Kari, L., W. M. Whitmire, J. H. Carlson, D. D. Crane, N. Reveneau, D. E. Nelson, D. C. Mabey, R. L. Bailey, M. J. Holland, G. McClarty, and H. D. Caldwell. 2008. Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J. Infect. Dis. 197:449-456.
12. Mabey, D. 2008. Trachoma: recent developments. Adv. Exp. Med. Biol. 609:98-107.
13. Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hickey, J. Peterson, T. Utterback, K. Berry, S. Bass, K. Linher, J. Weidman, H. Khouri, B. Craven, C. Bowman, R. Dodson, M. Gwinn, W. Nelson, R. DeBoy, J. Kolonay, G. McClarty, S. L. Salzberg, J. Eisen, and C. M. Fraser. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
14. Rice, P., I. Longden, and A. Bleasby. 2000. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16:276-277.
15. Rockey, D. D., W. Viratyosin, J. P. Bannantine, R. J. Suchland, and W. E. Stamm. 2002. Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions. Microbiology 148: 2497-2505.
16. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin, and R. W. Davis. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759.
17. Suchland, R. J., A. Bourillon, E. Denamur, W. E. Stamm, and D. M. Rothstein. 2005. Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil. Antimicrob. Agents Chemother. 49:1120-1126.
18. Suchland, R. J., D. D. Rockey, J. P. Bannantine, and W. E. Stamm. 2000. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect. Immun. 68:360-367.
19. Suchland, R. J., and W. E. Stamm. 1991. Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J. Clin. Microbiol. 29:1333-1338.
20. Wizel, B., B. C. Starcher, B. Samten, Z. Chroneos, P. F. Barnes, J. Dzuris, Y. Higashimoto, E. Appella, and A. Sette. 2002. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen. J. Immunol. 169:2524- 2535.
21. Xia, M., R. J. Suchland, R. E. Bumgarner, T. Peng, D. D. Rockey, and W. E. Stamm. 2005. Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response. J. Infect. Dis. 192: 1229-1236.